Ganirelix Acetate Salt API CAS 123246-29-7 | Peptide Manufacturer
Ganirelix Acetate Salt API CAS 123246-29-7 | Peptide Manufacturer
Ganirelix Acetate API,CAS 123246-29-7,Ganirelix Acetate,Custom Peptide Synthesis,Bulk Peptide Supplier,GnRH antagonist,controlled ovarian stimulation,cGMP Peptide Manufacturing
Source high-purity Ganirelix Acetate peptide API (CAS 123246-29-7) directly from cGMP manufacturer. Purity ≥99.0% by HPLC. Flexible packaging from mg to bulk kg for IVF formulation R&D.
Send Inquiry
Description
cGMP STANDARD PHARMACEUTICAL PEPTIDE SUPPLIER
Ganirelix Acetate Salt
CAS No.: 123246-29-7
Purity (HPLC)≥ 99.0%
Molecular FormulaC80H113N18O13 · 2C2H4O2
Molecular Weight1690.4 Da
Peptide Content / AcetateCustom / Controlled
💡 Quick Connection Notice: If your email link doesn't open, please directly send inquiries to: betty@pharma-sunrise.com
Scientific Overview & High-Quality Custom Peptide Synthesis
We specialize in the contract manufacturing and stable batch supply of high-purity Ganirelix Acetate API. Manufactured in strict accordance with cGMP and global regulatory quality standards, our peptide achieves excellent batch uniformity and highly stable physicochemical profiles. With a verified HPLC purity of ≥99.0%, our raw materials fully support laboratory process exploration, formulation research, and pilot scaling up to commercial-scale production.
Backed by rigorous quality control frameworks and flexible synthesis capabilities, we provide reliable, regulation-compliant peptide API solutions specifically tailored for the global assisted reproductive technology (ART) industry. We strive to be your stable, long-term strategic raw material supplier for clinical drug development and regulatory filing lifecycles.
Pharmacological Profile & API Formulation Targets
Mechanism of Action (MoA)
As a high-efficiency, third-generation synthetic GnRH antagonist, Ganirelix Acetate is a decapeptide that competitively binds to GnRH receptors on pituitary gonadotroph cells with exceptional affinity. It effectively blocks the binding of endogenous GnRH, offering immediate and sustained inhibition of LH and FSH secretion without inducing the initial hormonal flare-up effect characteristic of classic GnRH agonists.
Clinical Formulation Goals
When developed into finished injectable preparations under cGMP guidelines, this API is targeted for controlled ovarian stimulation (COS) protocols. The core clinical benchmarks focus on the effective suppression of premature mid-cycle LH surges, preventing premature follicle rupture, maintaining synchronous development of multiple follicles, and optimizing oocyte maturity and acquisition rates during IVF treatment.
Assisted Reproductive Research Expansion
Beyond standard generic drug evaluation, our Ganirelix Acetate serves as an essential analytical reference standard in Assisted Reproductive Research. It is widely applied in clinical comparative studies for ovulation induction scheme optimization, short-protocol cycle improvements, and fundamental endocrine mapping of pituitary hormone regulatory pathways.
Technical Specifications & Cold Chain Logistics Standards
| Product Identity | Ganirelix Acetate (Synthetic Decapeptide API) |
|---|---|
| Physical Characteristics | White to off-white hygroscopic lyophilized powder |
| Testing Method & Purity | High Performance Liquid Chromatography (HPLC); ≥ 99.0% |
| Flexible Packaging Options | • R&D Scale: 10–100 mg per protective glass vial • Pilot/Scaling Scale: 1–5 kg per advanced aluminum vacuum foil bag • Commercial Production: 25 kg inside heavy-duty fiber drums *Customized packaging configurations are fully supported upon request. |
| Storage & Transit Mandates | Store tightly sealed and dry at frozen conditions -20°C ± 5°C. Product is highly hygroscopic; protect diligently from light and moisture exposure. Avoid repeated freeze-thaw cycles. |
| Shelf Life Reference | 36 months under the proper recommended sealed and sub-zero storage conditions. |
Frequently Asked Questions (Peptide Procurement)
Can you guarantee the peptide sequence accuracy and provide batch testing data?
Yes. Our Ganirelix Acetate API undergoes rigorous solid-phase peptide synthesis (SPPS) and strict cGMP quality control. We provide a complete Certificate of Analysis (COA) with every batch, backed by comprehensive HPLC chromatograms (ensuring ≥99.0% purity) and Mass Spectrometry (MS) data to verify exact structural identity and molecular weight.
Do you accommodate custom packaging sizes for laboratory scale R&D?
Absolutely. We fully support reproductive R&D institutions and formulation developers. Beyond our commercial 1kg to 5kg foil bags, we provide highly precise mg-scale sterile vials (10mg - 100mg) specifically designed to facilitate early-stage pre-clinical trials and new drug formulation development.
How is the -20°C storage requirement managed during international shipping?
To ensure the complete integrity of the hygroscopic lyophilized peptide powder, we deploy specialized cold-chain logistics for all international shipments. The API is securely vacuum-sealed in moisture-proof aluminum foil and shipped utilizing validated temperature-controlled containers (e.g., dry ice/gel packs) to prevent any degradation during transit.
Is this API available for direct clinical injection or patient use?
No. As clearly stated in our declaration, this product is an active pharmaceutical ingredient and research chemical. It is strictly intended for industrial use, B2B finished drug manufacturing, and scientific research only. It cannot be used directly for human clinical medication or commercial cosmetic purposes.
Shaanxi Sunrise Pharmaceutical Co., Ltd.
Senior Independent Site Operations Specialist: Betty
📧 Email: betty@pharma-sunrise.com|💬 WhatsApp: +86 18092760627